Gene · 7305
Papers3,266
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,266
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and analysis of key immunity-related genes in experimental ischemic stroke. | Heliyon | 2024 | 39263122 | PubTator, text mining | PubMed |
| TYROBP serve as potential immune-related signature genes in the acute phase of intracerebral hemorrhage. | Sci Rep | 2024 | 39215129 | PubTator, text mining | PubMed |
| Identification of hub genes associated with neutrophils in chronic rhinosinusitis with nasal polyps. | Sci Rep | 2024 | 39191825 | PubTator, text mining | PubMed |
| Identification of crosstalk genes and immune characteristics between Alzheimer's disease and atherosclerosis. | Front Immunol | 2024 | 39188714 | PubTator, text mining | PubMed |
| DAP12 interacts with RER1 and is retained in the secretory pathway before assembly with TREM2. | Cell Mol Life Sci | 2024 | 39008111 | PubTator, text mining | PubMed |
| Unraveling the Molecular Dance: Insights into TREM2/DAP12 Complex Formation in Alzheimer's Disease through Molecular Dynamics Simulations. | ACS Omega | 2024 | 38973875 | PubTator, text mining | PubMed |
| Identification and validation of potential common biomarkers for papillary thyroid carcinoma and Hashimoto's thyroiditis through bioinformatics analysis and machine learning. | Sci Rep | 2024 | 38971817 | PubTator, text mining | PubMed |
| Mining and exploration of appendicitis nursing targets: An observational study. | Medicine (Baltimore) | 2024 | 38941398 | PubTator, text mining | PubMed |
| Elucidation of the effects of 2,5-hexandione as a metabolite of n-hexane on cognitive impairment in leptin-knockout mice (C57BL/6-Lepem1Shwl/Korl). | Toxicol Res | 2024 | 38911537 | PubTator, text mining | PubMed |
| Primary Microgliopathy Presenting as Degenerative Dementias: A Case Series of Novel Gene Mutations from India. | Dement Geriatr Cogn Dis Extra | 2024 | 38910897 | PubTator, text mining | PubMed |
| Novel Therapies for ANCA-associated Vasculitis: Apilimod Ameliorated Endothelial Cells Injury through TLR4/NF-κB Pathway and NLRP3 Inflammasome. | Curr Pharm Des | 2024 | 38910483 | PubTator, text mining | PubMed |
| Identification of common mechanisms and biomarkers for dermatomyositis and atherosclerosis based on bioinformatics analysis. | Skin Res Technol | 2024 | 38899746 | PubTator, text mining | PubMed |
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study. | Signal Transduct Target Ther | 2024 | 38871690 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing of human eosinophils in allergic inflammation in the esophagus. | J Allergy Clin Immunol | 2024 | 38871184 | PubTator, text mining | PubMed |
| Involvement of Siglec-15 in regulating RAP1/RAC signaling in cytoskeletal remodeling in osteoclasts mediated by macrophage colony-stimulating factor. | Bone Res | 2024 | 38849345 | PubTator, text mining | PubMed |
| Identification of crucial genes through WGCNA in the progression of gastric cancer. | J Cancer | 2024 | 38817876 | PubTator, text mining | PubMed |
| Cell autonomous microglia defects in a stem cell model of frontotemporal dementia. | medRxiv | 2024 | 38798451 | PubTator, text mining | PubMed |
| Editorial: The therapeutic inhibition of macrophage checkpoints. | Front Immunol | 2024 | 38736871 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers for GBM based on WGCNA. | Sci Rep | 2024 | 38724609 | PubTator, text mining | PubMed |
| Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition. | J Neuroinflammation | 2024 | 38664840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7305/papers?page=8